Aziyo biologics, inc. announces proposed public offering of common stock

Silver spring, md., nov. 30, 2022 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo) (“aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical devices and the patients they treat, today announced that it has commenced an underwritten public offering, subject to market and other conditions, of shares of its common stock. aziyo also intends to grant the underwriter a 30-day option to purchase additional shares of its common stock equal to 15% of the shares of common stock to be sold in the offering to cover over-allotments, if any. the offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering. all shares in the offering are to be sold by aziyo.
AZYO Ratings Summary
AZYO Quant Ranking